HemRid Anorectal Cream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: HemRid Anorectal Cream
Generic name: LIDOCAINE
Manufacturer: KKA & Associates LLC
Product type: HUMAN OTC DRUG
SPL set ID: dbeb4325-3e85-1147-e053-2995a90a2160
SPL ID: 4749b69f-2d02-1c2e-e063-6294a90ae960
Version: 4
Effective date: 2025-12-31
Source export date: 2026-09-28
Source partition: 2
Source file: https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/f7d2b6e3f8600cd856280ab55a9c6fa54a642647191d164f9d1110e89f3f4097/drug-label-0002-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:14:55

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M015	openfda.application_number
brand name		HemRid Anorectal Cream	openfda.brand_name
generic name		LIDOCAINE	openfda.generic_name
manufacturer name		KKA & Associates LLC	openfda.manufacturer_name
ndc	package	82620-001-01	openfda.package_ndc
ndc	product	82620-001	openfda.product_ndc
ndc11	package	82620000101	derived:openfda.package_ndc
rxcui		1366789	openfda.rxcui
spl id		4749b69f-2d02-1c2e-e063-6294a90ae960	id
spl set id		dbeb4325-3e85-1147-e053-2995a90a2160	set_id
unii		98PI200987	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

FOR EXTERNAL USE ONLY When using this product use only as directed. Avoid contact with eyes. do not exceed recommended dosage unless directed by a doctor. do not out this product into the rectum by using fingers or any mechanical device or applicator. Stop use and ask a doctor if rectal bleeding occurs. condition worsens or does not improve within 7 days. symptoms clear up and occur again within a few days. an allergic reaction develops to ingredients in this product. symptom being treated does not subside or if redness, irritation, swelling, pain or other symptoms develop or increase. If pregnant or breast-feeding, ask a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.